Matthew Harmon
Impact in
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
- biodegradable polymer synthesis and properties
- Silk-based biomaterials and applications
- Transplantation top 10%
Papers in
-
- Prostate Cancer Treatment and Research 8
- Oncology 6
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Sangamesh G. Kumbar (7 shared papers)Roshan James (6 shared papers)Daisy M. Ramos (3 shared papers)Aja Aravamudhan (2 shared papers)Namdev B. Shelke (3 shared papers)Meng Deng (1 shared paper)Xiaojun Yu (1 shared paper)Cato T. Laurencin (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Biomedical Nanotechnology (2 papers)Clinical Cancer Research (1 paper)Journal of Applied Polymer Science (1 paper)Biomaterials Science (1 paper)
- Partner nations
- United StatesChinaEgypt
In The Last Decade
Matthew Harmon
19 papers receiving 436 citations
Peers
Comparison fields: 5 of 80
- Biomaterials 190
- Transplantation 20
- Biomedical Engineering 192
- Molecular Medicine 17
- Urology 19
Countries citing papers authored by Matthew Harmon
This map shows the geographic impact of Matthew Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Harmon more than expected).
Fields of papers citing papers by Matthew Harmon
This network shows the impact of papers produced by Matthew Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Harmon. The network helps show where Matthew Harmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Harmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 98 | |
| 2 | 2013 | 85 | |
| 3 | 2014 | 64 | |
| 4 | 2014 | 60 | |
| 5 | 2020 | 44 | |
| 6 | 2007 | 21 | |
| 7 | 2023 | 13 | |
| 8 | 2022 | 12 | |
| 9 | 2015 | 12 | |
| 10 | 2013 | 10 | |
| 11 | 2014 | 7 | |
| 12 | 2015 | 7 | |
| 13 | 2019 | 6 | |
| 14 | 2020 | 2 | |
| 15 | 2014 | 2 | |
| 16 | 2020 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2019 | 1 |
About Matthew Harmon
Matthew Harmon is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biomaterials, Surgery and Biomedical Engineering, having authored 19 papers that have together received 447 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Bone Tissue Engineering Materials (3 papers), Animal Genetics and Reproduction (2 papers), biodegradable polymer synthesis and properties (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). The work is most often cited by research in Biomaterials (190 citations), Transplantation (20 citations), Biomedical Engineering (192 citations), Molecular Medicine (17 citations) and Urology (19 citations). Matthew Harmon has collaborated with scholars based in United States, China and Egypt. Frequent co-authors include Sangamesh G. Kumbar, Roshan James, Daisy M. Ramos, Aja Aravamudhan, Namdev B. Shelke, Meng Deng, Xiaojun Yu, Cato T. Laurencin, Xiaojun Yu and Ahmed A. Nada. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biomedical Nanotechnology, Clinical Cancer Research, Journal of Applied Polymer Science and Biomaterials Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.